Experimental vaccine trial offers hope for tough pancreatic cancer
NCT ID NCT07231094
Summary
This early-stage study is testing a new tumor vaccine injection combined with standard chemotherapy (AG regimen) for people with metastatic pancreatic cancer who haven't had previous treatment. The main goal is to check if the vaccine is safe and well-tolerated when given with chemotherapy, while also looking for early signs that it might help control the cancer. Only 13 participants will be enrolled in this initial safety-focused trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Third Xiangya Hospital of Central South University
Hunan, Changsha, 410000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.